Ka. Lapan et Pj. Fay, INTERACTION OF THE A1 SUBUNIT OF FACTOR VIIIA AND THE SERINE-PROTEASEDOMAIN OF FACTOR-X IDENTIFIED BY ZERO-LENGTH CROSS-LINKING, Thrombosis and haemostasis, 80(3), 1998, pp. 418-422
We have previously used a solid phase binding assay to localize a Fact
or X (FX) interactive site to the acidic C-terminus of the Al subunit
of FVIIIa (Lapan KA. Fay PJ. J Biol Chem 1997; 272: 2082-2088). The co
mplex of FVIII-FX was made covalent following reaction with the zero-l
ength cross-linking reagent 1-ethyl-3-(3-dimethylaminopropyl-)carbodii
mide hydrochloride (EDC). Western blotting of the thrombin-cleaved com
plex showed that the AI subunit of FVIIIa associated with FX heavy cha
in. The FX-AI product was also detected following cross-linking to the
A1/A3-C1-C2 dimer, but not the activated protein C-cleaved A1(336)/A3
-C1-C2 form, indicating that a residue(s) in the region spanning Met(3
37)-Arg(372) contributed to the intermolecular ion pair(s). A syntheti
c peptide to this acidic region (FVIII337-372) cross-linked to FX and
the product was alkaline resistant indicating that amide linkage(s) we
re formed. Sequence analysis of the FX-FVIII337-372 adduct suggested t
hat the first 12 NH2-terminal residues of the FX and peptide do not pa
rticipate in cross-link formation. Conversion of the cross-linked prod
uct to FXa by RW-X showed that the peptide was associated with the ser
ine protease-forming domain of the heavy chain. These results indicate
that the association of FVIIIa and FX occurs from a salt linkage(s) f
ormed between residues of the Al acidic C-terminus of the cofactor (wi
thin residues 349-372) and the serine protease-forming domain of the s
ubstrate.